Socio-Epidemiological Factors with Negative Impact on Infant Morbidity, Mortality Rates, and the Occurrence of Birth Defects.
chromosomal and genetic conditions
infant
morbidity
mortality
socioeconomic status
Journal
Healthcare (Basel, Switzerland)
ISSN: 2227-9032
Titre abrégé: Healthcare (Basel)
Pays: Switzerland
ID NLM: 101666525
Informations de publication
Date de publication:
01 Apr 2021
01 Apr 2021
Historique:
received:
19
02
2021
revised:
18
03
2021
accepted:
24
03
2021
entrez:
30
4
2021
pubmed:
1
5
2021
medline:
1
5
2021
Statut:
epublish
Résumé
In the last 30-40 years, developed countries in particular, but also developing ones, have seen an increase in life expectancy and a decrease in infant mortality and morbidity rates. These factors are due to an increase in living standards, a decrease in differences between social classes, the increased accessibility of education to women, and the implementation of some public health measures. When certain basic social and medical measures are implemented on a large scale, their benefits are first reflected in lower infant mortality rates, and only in the second stage are such benefits reflected in decreasing neonatal mortality rates and a smaller number of stillbirths. In this study, we review the literature on these factors. We extrapolate and compare this literature with data recorded in our country in the hopes of finding the reasons why Romania ranks first in the European Union in terms of infant mortality rates. We found that lowering the infant morbidity, mortality, and congenital malformation rates is an absolute priority in Romania, which requires the involvement of decision makers in taking effective measures regarding food supplementation or enhancement using folic acid, adequate counselling of couples, monitoring of all pregnancies, setting antenatal diagnosis, implementing optimal delivery management and therapeutic approaches to problematic pregnancies in other hospitals and by involving the population in health education, avoiding occupational or in-home exposure to toxic factors, avoiding drug use, and implementing disease and infection prevention measures for pregnant women.
Identifiants
pubmed: 33915730
pii: healthcare9040384
doi: 10.3390/healthcare9040384
pmc: PMC8065913
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Références
Lancet. 2018 Nov 10;392(10159):1736-1788
pubmed: 30496103
Lancet. 1999 Dec 4;354(9194):1955-61
pubmed: 10622298
Am J Epidemiol. 2008 Feb 15;167(4):485-91
pubmed: 18063593
Teratology. 1996 Aug;54(2):84-92
pubmed: 8948544
Placenta. 2016 Nov;47:37-45
pubmed: 27780538
BMC Pregnancy Childbirth. 2010 Feb 23;10 Suppl 1:S7
pubmed: 20233388
Am J Med Genet. 1995 Aug 28;58(2):187-94
pubmed: 8533813
Pediatrics. 2002 May;109(5):904-8
pubmed: 11986454
Prenat Diagn. 2002 Aug;22(8):715-7
pubmed: 12210582
J Biomed Biotechnol. 2011;2011:
pubmed: 20936111
Ann Nutr Metab. 2019;74(2):93-106
pubmed: 30673669
Epidemiology. 2010 Mar;21(2):232-9
pubmed: 20087193
Birth Defects Res C Embryo Today. 2015 Jun;105(2):140-56
pubmed: 26043938
J Toxicol Environ Health A. 2006 Jul;69(13):1253-9
pubmed: 16754539
Nat Commun. 2020 Nov 25;11(1):5980
pubmed: 33239672
BMJ. 2009 May 12;338:b1673
pubmed: 19436079
Lancet Diabetes Endocrinol. 2016 May;4(5):393-402
pubmed: 26944421
Am J Hum Genet. 1995 Aug;57(2):227-32
pubmed: 7668246
Chirurgia (Bucur). 2014 Jul-Aug;109(4):507-13
pubmed: 25149614
Lancet. 2014 Jul 26;384(9940):347-70
pubmed: 24853604
Int J Neonatal Screen. 2019 Aug 22;5(3):26
pubmed: 33072985
BMC Pregnancy Childbirth. 2015;15 Suppl 2:S4
pubmed: 26391000
Chirurgia (Bucur). 2015 Mar-Apr;110(2):151-6
pubmed: 26011837
J Epidemiol Community Health. 2002 Jul;56(7):538-41
pubmed: 12080163
Turk Pediatri Ars. 2020 Sep 01;55(Suppl 1):69-84
pubmed: 32963483
BMJ. 2001 Aug 18;323(7309):363-8
pubmed: 11509424
J Pediatr. 2011 Nov;159(5):825-831.e1
pubmed: 21679965
F1000Res. 2020 Jul 14;9:702
pubmed: 33224477
Int J Occup Med Environ Health. 2016;29(3):461-70
pubmed: 26988884
BMJ. 1993 Feb 20;306(6876):499-503
pubmed: 8448464
Lancet. 2004 Jul 31-Aug 6;364(9432):399-401
pubmed: 15288723
Eur J Obstet Gynecol Reprod Biol. 2002 Mar 10;101(2):147-54
pubmed: 11858890
Am J Obstet Gynecol. 2011 May;204(5):404.e1-404.e10
pubmed: 21396620
Int J Epidemiol. 2010 Apr;39 Suppl 1:i122-33
pubmed: 20348115
Bull World Health Organ. 2007 Oct;85(10):798-804
pubmed: 18038062
Vaccine. 2019 May 31;37(25):3267-3277
pubmed: 31072733
World J Surg. 2015 Jan;39(1):36-40
pubmed: 25135175
Eur J Public Health. 2009 Apr;19(2):161-7
pubmed: 19221022
Eur J Pediatr Surg. 2002 Apr;12(2):90-4
pubmed: 12015651
Lancet. 2014 Jul 12;384(9938):189-205
pubmed: 24853593
BMC Public Health. 2011 Apr 13;11 Suppl 3:S12
pubmed: 21501429
Birth Defects Res A Clin Mol Teratol. 2004 Sep;70(9):572-9
pubmed: 15368555
J Pediatr Urol. 2007 Aug;3(4):305-10
pubmed: 18947761
Birth Defects Res A Clin Mol Teratol. 2003 Sep;67(9):617-24
pubmed: 14703783
Orphanet J Rare Dis. 2009 Oct 30;4:23
pubmed: 19878548
Health Res Policy Syst. 2015 Nov 25;13 Suppl 1:49
pubmed: 26792061
Lancet. 2014 Sep 13;384(9947):957-79
pubmed: 24797572
Hum Reprod. 2007 Mar;22(3):696-701
pubmed: 17164268
Am J Epidemiol. 2002 Jan 1;155(1):17-25
pubmed: 11772780
Reprod Health. 2013;10 Suppl 1:S4
pubmed: 24625215
Int J Epidemiol. 2010 Apr;39 Suppl 1:i110-21
pubmed: 20348114
Am J Epidemiol. 2002 Jan 1;155(1):26-31
pubmed: 11772781
Ann Genet. 2001 Oct-Dec;44(4):201-8
pubmed: 11755106